hydralazine has been researched along with labetalol in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (33.03) | 18.7374 |
1990's | 14 (12.84) | 18.2507 |
2000's | 14 (12.84) | 29.6817 |
2010's | 33 (30.28) | 24.3611 |
2020's | 12 (11.01) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
Craswell, PW; De Voss, K; Williams, JG | 1 |
Havard, CW; Pearson, RM | 1 |
Barnett, AJ; Guest, C; Kalowski, S | 1 |
Allonen, H; Kleimola, T; Lehtonen, A | 1 |
Boakes, AJ; Joekes, AM; Prichard, BN; Thompson, FO | 1 |
Barratt, TM; Deal, JE; Dillon, MJ | 1 |
Bunchman, TE; Lynch, RE; Wood, EG | 1 |
Stumpf, JL | 1 |
Fairlie, FM; Walker, JJ | 1 |
Ram, CV | 2 |
Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
Harper, A; Murnaghan, GA | 1 |
Imai, S; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
Dimich, I; Gabrielson, G; Kaplan, JA; Lingham, R; Singh, PP | 1 |
Littler, WA; Smith, SA | 1 |
Naden, RP; Redman, CW | 1 |
Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M | 1 |
Akashi, A; Hashimoto, H; Kanda, A; Tanaka, M | 1 |
Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
Ferguson, RK; Vlasses, PH | 1 |
Vidt, DG | 1 |
Gertel, M; Shapira, Y | 1 |
Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM | 1 |
Ashe, RG; Moodley, J; Philpott, RH; Richards, AM | 1 |
Burris, JF | 1 |
Booth, RJ; Bullock, JY; Wilson, JD | 1 |
Riley, AJ | 1 |
Prichard, BN; Richards, DA | 1 |
Almazov, VA; Bondarenko, BB; Shabrov, AV | 1 |
Lubbe, WF | 1 |
Prichard, BN | 1 |
Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
Calder, AA; Greer, I; Walker, JJ | 1 |
Chalmers, JP; Graham, JR; Grygiel, JJ; Mulligan, J; Walkley, J; West, MJ; Wing, LM | 1 |
Corvol, P; Lardoux, MD; Thibonnier, M | 1 |
Donker, AJ; May, JF; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
Davey, DA; Dommisse, J; Garden, A | 1 |
Colombo, G; Fea, F; Foti, F; Pelliccioli, I; Planca, E; Salvioli, G | 1 |
Dage, RC; Hsieh, CP | 1 |
Broughton Pipkin, F; Lamming, GD; Symonds, EM | 1 |
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D | 1 |
Connelly, JF; Zigmont, EA | 1 |
Belfrage, P; Faxelius, G; Hjertberg, R | 1 |
Arner, P; Galitzky, J; Lafontan, M; Nordenström, J | 1 |
Faxelius, G; Hjertberg, R; Lagercrantz, H | 1 |
Abdelwahab, W; Frishman, W; Landau, A | 1 |
al-Qattan, F; Makhseed, M; Omu, AE | 1 |
Bull, SB; Koren, G; Logan, A; Magee, LA | 1 |
Hussein, M; Mooij, JM; Roujouleh, H | 1 |
Bogaru, A; Cachat, F; Guignard, JP; Lepori, D; Micheli, JL | 1 |
Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N | 1 |
Heazell, AE; Mahomoud, S; Pirie, AM | 1 |
Hamilton, R; Lim, K; Prasad, GV; Vincent, L | 1 |
de Jaramillo, IA; López, JC; Pinzón, J; Ruiz, E; Vega-Maleck, JC; Vigil-De Gracia, P | 1 |
Al-Harmi, J; Al-Ragum, NS; Mlechkova, L; Omu, AE; Sayed, AF; Vedi, HL | 1 |
Abbott, J; Bakes, K; Withers, E; Yancey, LM | 1 |
Marik, PE; Varon, J | 1 |
Erickson, S; Weder, AB | 1 |
Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP | 1 |
Gong, SP; Huang, LP; Liu, QQ; Yu, YH | 1 |
Abudiab, MM; Odunukan, OW; Sinak, LJ | 1 |
Alexander, JM; Wilson, KL | 1 |
Arulkumaran, N; Lightstone, L | 1 |
Buck, BH; Butcher, KS; Choi, V; Coutts, SB; Demchuk, AM; Dowlatshahi, D; Emery, DJ; Gould, BE; Hansen, MB; Hill, MD; Kate, MP; McCourt, R; Mouridsen, K; Østergaard, L | 1 |
Charlton, F; Hennessy, A; Makris, A; Xu, B | 1 |
Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P | 1 |
Gangooly, S; Jauniaux, E; Muttukrishna, S | 1 |
Simon, M; Vadhera, RB | 1 |
Anderson, B; Bautista, L; Bofill, J; Darby, M; Kiprono, L; Martin, JN; Morris, R; Novotny, S; Sawardecker, S; Sunesara, I | 1 |
Cortes, J; Hall, AB; McKay, C | 1 |
Olson-Chen, C; Seligman, NS | 1 |
Abreo, A; Greene, N; Kilpatrick, SJ; Main, EK; Melsop, K; Peterson, N; Shields, LE | 1 |
Aghajanian, P; Greene, N; Kilpatrick, SJ; Rodriguez, M; Sharma, KJ | 1 |
Chawla, N; Kim, RK; Legler, A | 1 |
Bobek, G; Hennessy, A; Makris, A; Xu, B | 1 |
Barton, JR; Sibai, BM | 1 |
Kilpatrick, SJ; Sharma, KJ | 1 |
Amaral, LM; LaMarca, B; Owens, M; Wallace, K | 1 |
Gaynor, MF; Vondracek, S; Wright, GC | 1 |
Flynn, JT; Starr, MC | 1 |
Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K | 1 |
Sequeira, RP; Sridharan, K | 1 |
Dierkhising, RA; Kuper, PJ; Mara, KC; Poyant, JO; Rabinstein, AA; Ritchie, BM; Wijdicks, EFM | 1 |
Chams, N; Gjeka, R; Kumar, S; Peterson, D; Ross, I; Salman, A; Salman, J; Tegeltija, V | 1 |
Carrera, JF; Chiota-McCollum, NA; Sorace, BJ; Southerland, AM; Worrall, BB | 1 |
Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM | 1 |
Chera-Aree, P; Leetheeragul, J; Sampaojarean, U; Surasereewong, S; Tengtrakulcharoen, P; Wataganara, T | 1 |
Cawoski, JR; Covvey, JR; DeBiasio, KA; Donnachie, SW; Guarascio, AJ; Montepara, CA; Nemecek, BD; Timanus, EA; Zimmerman, DE | 1 |
Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN | 1 |
Behymer, TP; Bettin, M; Christianson, T; Coleman, ER; Divani, A; Flaherty, ML; Gilkerson, LA; James, ML; King, NKK; Krishnamoorthy, V; Langefeld, CD; McCauley, JL; Ng, Y; Qi, W; Shah, S; Testai, FD; Walsh, KB; Woo, D | 1 |
Bako, B; Dawha, YM; Muhammad, S; Usman, H; Yahya, A; Yekeen, A | 1 |
Greene, NH; Kilpatrick, SJ; Pon, FF | 1 |
Hoffman, MC; Wautlet, CK | 1 |
Cho, I; Choe, KR; Jeong, DE; Kim, HJ; Kim, MK; Lee, KN; Park, JY | 1 |
Hamidy, Y; Novri, DA; S, D; Savira, M | 1 |
Husain, S; Hussain, R; Kausar, M | 1 |
30 review(s) available for hydralazine and labetalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
Fatal hepatotoxicity induced by hydralazine or labetalol.
Topics: Aged; Chemical and Drug Induced Liver Injury; Humans; Hydralazine; Hypertension; Labetalol; Male | 1991 |
Management of hypertensive emergencies: changing therapeutic options.
Topics: Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Nitroprusside | 1991 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus | 1985 |
Hypertensive emergencies and urgencies.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroglycerin; Nitroprusside; Risk; Trimethaphan | 1986 |
[New drugs for deliberate hypotension in anesthesia].
Topics: Anesthesia; Animals; Humans; Hydralazine; Hypotension, Controlled; Isoflurane; Labetalol | 1988 |
Comparison of labetalol with other anti-hypertensive drugs.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Ethanolamines; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa | 1982 |
[Mechanism of development and principles of treatment of malignant arterial hypertension].
Topics: Adrenergic beta-Antagonists; Anemia, Hemolytic; Animals; Antihypertensive Agents; Cyclic AMP; Factor XII; Humans; Hydralazine; Hypertension, Malignant; Labetalol; Platelet Aggregation; Prostaglandins F; Rabbits; Rats; Renin-Angiotensin System; Thromboplastin; Vasopressins; Water-Electrolyte Imbalance | 1983 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus | 1984 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
Management of hypertensive urgencies and emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Emergencies; Enalaprilat; Female; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside | 1995 |
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Cohort Studies; Databases as Topic; Diabetes, Gestational; Female; Gestational Age; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Prospective Studies; Racial Groups; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Perioperative hypertension management.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents | 2008 |
[Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Nifedipine; Perinatal Mortality; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Severity of Illness Index | 2012 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; Fetal Monitoring; Humans; Hydralazine; Infusions, Intravenous; Labetalol; Methyldopa; Nifedipine; Nitroprusside; North America; Oliguria; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 2013 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom | 2013 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Severity of Illness Index | 2014 |
Hypertensive Emergencies in Pregnancy.
Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; Esophageal Atresia; Female; Heart Defects, Congenital; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Hypospadias; Labetalol; Labor, Induced; Male; Nifedipine; Postnatal Care; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prevalence; United States | 2016 |
Postpartum Hypertension: Etiology, Diagnosis, and Management.
Topics: Antihypertensive Agents; Blood Pressure; Disease Management; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Postpartum Period; Pregnancy; Puerperal Disorders | 2017 |
Pathophysiology and Current Clinical Management of Preeclampsia.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delivery, Obstetric; Endothelium, Vascular; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Inflammation; Ischemia; Labetalol; Magnesium Sulfate; Placenta; Pre-Eclampsia; Pregnancy; Premature Birth | 2017 |
Neonatal hypertension: cases, causes, and clinical approach.
Topics: Administration, Intravenous; Antihypertensive Agents; Birth Weight; Blood Pressure; Blood Pressure Determination; Clinical Decision-Making; Gestational Age; Humans; Hydralazine; Hypertension; Incidence; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Intensive Care Units, Neonatal; Kidney; Labetalol; Neuroblastoma; Reference Values; Renal Artery Obstruction; Severity of Illness Index; Treatment Outcome | 2019 |
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalaprilat; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Intracranial Hemorrhages; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pyridines; Stroke | 2018 |
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hypertension; Hypotension; Incidence; Labetalol; Network Meta-Analysis; Nifedipine; Perinatal Death; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stillbirth; Tachycardia; Treatment Outcome | 2018 |
Safety and efficacy of intravenous hydralazine and labetalol for the treatment of asymptomatic hypertension in hospitalised patients: A systematic review.
Topics: Administration, Intravenous; Antihypertensive Agents; Humans; Hydralazine; Hypertension; Labetalol | 2021 |
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Network Meta-Analysis; Nifedipine; Pregnancy; Randomized Controlled Trials as Topic | 2022 |
Hypertensive Crisis in Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Pregnancy | 2022 |
26 trial(s) available for hydralazine and labetalol
Article | Year |
---|---|
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Patient Compliance; Pindolol | 1978 |
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol; Time Factors | 1979 |
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Diazoxide; Drug Therapy, Combination; Ethanolamines; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Physical Exertion; Posture; Propranolol | 1975 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Cardiovascular; Pulsatile Flow; Random Allocation; Umbilical Arteries | 1991 |
Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
Topics: Aged; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Postoperative Complications; Tachycardia | 1989 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Hydralazine; Hypertension; Labetalol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1987 |
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
Topics: Blood Pressure; Clinical Trials as Topic; Dihydralazine; Female; Heart Rate; Heart Rate, Fetal; Humans; Hydralazine; Hypertension; Labetalol; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation; Time Factors | 1987 |
Antinuclear antibodies in patients on acebutolol.
Topics: Adrenergic Agonists; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Humans; Hydralazine; Labetalol; Male; Phentolamine; Placebos | 1980 |
Some further evidence for partial agonist activity of labetalol.
Topics: Adrenergic Agonists; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Humans; Hydralazine; Labetalol; Male; Phentolamine; Placebos | 1980 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
Topics: Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular | 1983 |
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol | 1980 |
Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
Topics: Acebutolol; Adult; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Renin | 1980 |
Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Time Factors | 1982 |
Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
Topics: Adult; Blood Pressure; Dihydralazine; Eclampsia; Ethanolamines; Female; Fetus; Humans; Hydralazine; Infant, Newborn; Infusions, Parenteral; Labetalol; Pre-Eclampsia; Pregnancy; Random Allocation | 1982 |
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Labor, Obstetric; Metabolic Clearance Rate; Methyldopa; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular; Sodium; Uric Acid | 1980 |
Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
Topics: Adult; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Labetalol; Pre-Eclampsia; Pregnancy; Pregnancy Outcome | 1993 |
Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4.
Topics: Adult; Antihypertensive Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Infusions, Intravenous; Interleukin-4; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy | 1996 |
Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Infusions, Intravenous; Labetalol; Panama; Postpartum Period; Research Design; Severity of Illness Index; Treatment Outcome | 2007 |
Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
Topics: Acute Disease; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Middle Cerebral Artery; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Statistics, Nonparametric; Treatment Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal; Umbilicus | 2011 |
Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Hematoma; Humans; Hydralazine; Labetalol; Male; Oxygen Consumption; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiography, Impedance; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Pilot Projects; Pregnancy; Prospective Studies; Vascular Resistance; Young Adult | 2016 |
Initial antihypertensive agent effects on acute blood pressure after intracerebral haemorrhage.
Topics: Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine | 2022 |
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant; Infant, Newborn; Labetalol; Nigeria; Perinatal Death; Pre-Eclampsia; Pregnancy | 2022 |
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy | 2022 |
53 other study(ies) available for hydralazine and labetalol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Labetalol in the treatment of hypertensive renal patients.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Kidney Failure, Chronic; Labetalol; Male; Middle Aged; Minoxidil; Time Factors | 1978 |
Treatment of severe and resistant hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroprusside; Patient Dropouts; Trimethaphan; Vasodilator Agents | 1978 |
Management of hypertensive emergencies.
Topics: Adolescent; Child; Child, Preschool; Diazoxide; Emergencies; Female; Humans; Hydralazine; Hypertension; Infant; Infusions, Intravenous; Injections, Intramuscular; Labetalol; Male; Nitroprusside | 1992 |
Intravenously administered labetalol for treatment of hypertension in children.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Diazoxide; Heart Rate; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Nitroprusside; Potassium; Time Factors | 1992 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Female; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular | 1991 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors | 1985 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |
Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Hydralazine; Hypertension; Labetalol; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Vasodilator Agents | 1988 |
Current concepts in treatment of hypertensive emergencies.
Topics: Diazoxide; Drug Therapy, Combination; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Phentolamine; Reserpine; Sympathomimetics; Trimethaphan; Vasodilator Agents | 1986 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
Hypertensive emergencies.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroprusside; Propranolol; Risk; Trimethaphan | 1985 |
[Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1981 |
Direct vasodilatation by labetalol in anaesthetized dogs.
Topics: Adrenalectomy; Anesthesia; Animals; Clonidine; Diazoxide; Dogs; Ethanolamines; Female; Hemodynamics; Hydralazine; Labetalol; Male; Vagotomy; Vasodilator Agents | 1980 |
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic | 1994 |
Intravenous antihypertensive agents for patients unable to take oral medications.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Enalaprilat; Furosemide; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1995 |
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
Topics: Adipose Tissue; Adult; Analysis of Variance; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Ethanol; Female; Glycerol; Humans; Hydralazine; Kinetics; Labetalol; Lipid Mobilization; Male; Nitroprusside; Propranolol; Receptors, Adrenergic, alpha; Time Factors; Yohimbine | 1993 |
Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
Topics: Adolescent; Adult; Female; Fetal Hypoxia; Hemodynamics; Humans; Hydralazine; Infant, Newborn; Labetalol; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Sweden | 1993 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; Fetal Death; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Multivariate Analysis; Nifedipine; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Pregnancy Outcome; Retrospective Studies; Risk Factors | 2001 |
Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta, Abdominal; Blood Pressure; Captopril; Diuretics; Female; Furosemide; Humans; Hydralazine; Hypertension, Renovascular; Infant, Newborn; Labetalol; Magnetic Resonance Imaging; Nitroprusside; Proteinuria; Radiography; Renal Artery Obstruction | 2004 |
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance | 2004 |
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
Topics: Antihypertensive Agents; Female; Hospital Units; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Obstetrics; Practice Patterns, Physicians'; Pregnancy | 2004 |
Minimal change disease in association with fire coral (Millepora species) exposure.
Topics: Acute Kidney Injury; Animals; Anthozoa; Barbados; Bites and Stings; Combined Modality Therapy; Diving; Edema; Female; Forearm Injuries; Furosemide; Humans; Hydralazine; Intubation, Intratracheal; Labetalol; Marine Toxins; Middle Aged; Mitral Valve Insufficiency; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Pulmonary Edema; Ramipril | 2006 |
Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Eclampsia; Female; Humans; Hydralazine; Kuwait; Labetalol; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk Factors; Tocolytic Agents; Treatment Outcome | 2008 |
Postpartum preeclampsia: emergency department presentation and management.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Antihypertensive Agents; Benzodiazepines; Eclampsia; Emergency Medicine; Female; Headache; Humans; Hydralazine; Hypertension; Labetalol; Magnesium Sulfate; Postpartum Period; Pre-Eclampsia; Pregnancy; Retrospective Studies; Seizures; Vision Disorders; Young Adult | 2011 |
Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine.
Topics: Adult; Aged; Antihypertensive Agents; Female; Hospitalization; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2010 |
Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
Topics: Algorithms; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Pregnancy | 2011 |
48-year-old man with cough and leg swelling.
Topics: Acute Disease; Antihypertensive Agents; Cerebrovascular Circulation; Cough; Dyspnea; Echocardiography; Edema; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Lower Extremity; Male; Metoprolol; Middle Aged; Nitroglycerin; Sleep Apnea Syndromes; Vasodilator Agents | 2012 |
Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro.
Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Cytokines; Endothelium, Vascular; Female; Humans; Hydralazine; In Vitro Techniques; Labetalol; Methyldopa; Trophoblasts | 2014 |
In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
Topics: Activins; Angiogenic Proteins; Antigens, CD; Antihypertensive Agents; Chorionic Gonadotropin; Chorionic Villi; Dose-Response Relationship, Drug; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Labetalol; Methyldopa; Placenta; Placental Hormones; Pravastatin; Pre-Eclampsia; Pregnancy; Receptors, Cell Surface; Time Factors; Tissue Culture Techniques; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 2015 |
Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Topics: Adult; Antihypertensive Agents; California; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Morbidity; Nifedipine; Pregnancy; Retrospective Studies; Young Adult | 2016 |
Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Hypotension; Labetalol; Pre-Eclampsia; Pregnancy; Risk Assessment | 2016 |
Glucagon-induced hypertensive emergency: a case report.
Topics: Antihypertensive Agents; Emergencies; Female; Gastrointestinal Agents; Glucagon; Humans; Hydralazine; Hypertension; Labetalol; Middle Aged; Nitroglycerin; Vasodilator Agents | 2016 |
Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks.
Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hydralazine; Interleukin-1 Receptor-Like 1 Protein; Labetalol; Methyldopa; Nitric Oxide Synthase Type III; Trophoblasts; Tumor Necrosis Factor-alpha; Uterus | 2017 |
Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Pre-Eclampsia; Pregnancy | 2017 |
Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adrenergic Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Colorado; Drug Utilization Review; Electronic Health Records; Female; Hospitalization; Hospitals, University; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Vasodilator Agents | 2018 |
Nicardipine Reduces Blood Pressure Variability After Spontaneous Intracerebral Hemorrhage.
Topics: Administration, Intravenous; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Humans; Hydralazine; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Treatment Outcome | 2019 |
Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety.
Topics: Administration, Intravenous; Antihypertensive Agents; Enalapril; Female; Health Personnel; Hospitals; Humans; Hydralazine; Hypertension; Labetalol; Patient Safety; Quality Improvement; Retrospective Studies | 2019 |
Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome | 2020 |
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; Black or African American; Chronic Disease; Emergencies; Ethnicity; Female; Gestational Age; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Labor, Obstetric; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Retrospective Studies; Risk Factors; Severity of Illness Index; Time-to-Treatment; White People | 2020 |
Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
Topics: Administration, Intravenous; Adult; Antihypertensive Agents; Apgar Score; Asian People; Blood Pressure; Cesarean Section; Female; Heart Rate, Fetal; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Magnesium Sulfate; Pregnancy; Retrospective Studies; Seizures; Treatment Outcome; Young Adult | 2020 |
Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Ethnicity; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Peripartum Period; Pregnancy; Retrospective Studies | 2022 |
Use of continuous infusion of nicardipine to control persistent postpartum hypertension: A retrospective study.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Postpartum Period; Pregnancy; Retrospective Studies | 2022 |
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypotension; Labetalol; Pre-Eclampsia; Pregnancy; Pregnant Women | 2023 |